CompletedNot Applicable

Assess the Performance of Metagenomic Sequencing in the Diagnosis of STI (NGS-IST)

France332 participantsStarted 2022-07-11

Plain-language summary

The main objective of the study will be to assess the performance of the Next-Generation-Sequencing (NGS) diagnostics of Chlamydia trachomatis and Neisseria gonorrhoeae compared to reference techniques.

Who can participate

Age range18 Years

SexMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age ≥ 18 years old * MSM * PrEP users * Acceptance of study constraints * With or without Social Security scheme or State Medical Aid * Signature of consent form to participate in the study Exclusion Criteria: * Language barrier making questioning impossible.

What they're measuring

To evaluate the performance of NGS metagenomic diagnosis of Chlamydia trachomatis (Ct) and Neisseria gonorrhoeae (Ng) compared to reference techniques.

Timeframe: 12 months

Trial details

NCT IDNCT05581160

SponsorInstitut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-09-27

View on ClinicalTrials.gov More Sexually Transmitted Infections (Not HIV or Hepatitis) trials